 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This indicator may be signaling DVAX's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Dynavax Technologies (DVAX, $12.41) entered Uptrend as Momentum indicator ascends above 0 level on Mar 27, 2024

This is a Bullish indicator signaling DVAX's price could rise from here. Traders may explore going long the stock or buying call options...

Dynavax Technologies (DVAX, $12.5) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 25, 2024

Dynavax Technologies (NASDAQ:DVAX  Get Free Report) and Jaguar Health (NASDAQ:JAGX  Get Free Report) are both small-cap medical companies, but which is the better investment? We will...

Comparing Dynavax Technologies (NASDAQ:DVAX) & Jaguar Health (NASDAQ:JAGX)

Public Sector Pension Investment Board lessened its holdings in Dynavax Technologies Co. (NASDAQ:DVAX  Free Report) by 24.9% during the 3rd quarter, according to its most recent filing with...

Public Sector Pension Investment Board Sells 52,914 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)

Investors in Dynavax Technologies Corp (DVAX) saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX...

First Week of May 17th Options Trading For Dynavax Technologies (DVAX)

StockNews.com upgraded shares of Dynavax Technologies (NASDAQ:DVAX  Free Report) from a hold rating to a buy rating in a research note published on Wednesday.
DVAX has been the subject of...

Dynavax Technologies (NASDAQ:DVAX) Upgraded to "Buy" at StockNews.com

Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX)

Teza Capital Management LLC trimmed its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX  Free Report) by 26.4% in the third quarter, according to its most recent filing with the...

Teza Capital Management LLC Reduces Stock Position in Dynavax Technologies Co. (NASDAQ:DVAX)

Rhumbline Advisers decreased its position in shares of Dynavax Technologies Co. (NASDAQ:DVAX  Free Report) by 15.0% during the third quarter, according to the company in its most recent...

Rhumbline Advisers Sells 54,241 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)

Dynavax Technologies Co. (NASDAQ:DVAX  Free Report)  Research analysts at William Blair upped their Q3 2024 earnings per share (EPS) estimates for Dynavax Technologies in a research...

Q3 2024 EPS Estimates for Dynavax Technologies Co. Lifted by Analyst (NASDAQ:DVAX)

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Volume (M)	1.00
52-Wk High	$15.15
52-Wk Low	$10.06

DVAX Dynavax Technologies Corp.

About

Feed

News

Sentiment

Earnings

Fundamentals